CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER

被引：94

作者：

BISHOP, JF

RAGHAVAN, D

STUARTHARRIS, R

MORSTYN, G

ARONEY, R

KEFFORD, R

YUEN, K

LEE, J

GIANOUTSOS, P

OLVER, IN

ZALCBERG, J

BALL, D

BULL, C

FOX, R

机构：

[1] LUDWIG INST CANC RES,CH-1066 EPALINGES,SWITZERLAND

[2] ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA

[3] ROYAL PRINCE ALFRED HOSP,CAMPERDOWN,NSW 2050,AUSTRALIA

[4] UNIV SYDNEY,WESTMEAD CTR,WESTMEAD,NSW 2145,AUSTRALIA

[5] REPATRIAT GEN HOSP,MELBOURNE,AUSTRALIA

来源：

关键词：

D O I：

10.1200/JCO.1987.5.10.1574

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1574 / 1578

页数：5

共 20 条

[1] AISNER J, 1982, CANCER TREAT REP, V66, P221
[2] CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE
CANETTA, R
ROZENCWEIG, M
CARTER, SK
[J]. CANCER TREATMENT REVIEWS, 1985, 12 : 125 - 136
[3] PHASE-II STUDY WITH CIS-DICHLORODIAMMINEPLATINUM-(II) IN SMALL CELL ANAPLASTIC BRONCHOGENIC-CARCINOMA
CAVALLI, F
GOLDHIRSCH, A
SIEGENTHALER, P
KAPLAN, S
BEER, M
[J]. EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) : 617 - 621
[4] DIXON WJ, 1981, BMDP STATISTICAL SOF, P330
[5] DOMBERNOWSKY P, 1979, CANCER TREAT REP, V63, P543
[6] EGORIN MJ, 1984, CANCER RES, V44, P5432
[7] EVANS W K, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P169
[8] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER
EVANS, WK
OSOBA, D
FELD, R
SHEPHERD, FA
BAZOS, MJ
DEBOER, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 65 - 71
[9] Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4
[10] PRECLINICAL STUDIES ON TOXICITY, ANTITUMOUR ACTIVITY AND PHARMACOKINETICS OF CISPLATIN AND 3 RECENTLY DEVELOPED DERIVATIVES
LELIEVELD, P
VANDERVIJGH, WJF
VELDHUIZEN, RW
VANVELZEN, D
VANPUTTEN, LM
ATASSI, G
DANGUY, A
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08): : 1087 - 1104